[1]
Shi M,
Cai Q,
Yao L,
Mao Y,
Ming Y,
Ouyang G. Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells.
Cell Biol Int 2006; 30(3): 221-6.
[2]
Salvioli S,
Sikora E,
Cooper EL,
Franceschi C. Curcumin in cell death processes: a challenge for CAM of age-related pathologies. Evid Based Complement Alternat Med 2007; 4(2): 181-90.
[3]
Anand P,
Kunnumakkara AB,
Newman RA,
Aggarwal BB. Bioavailability of curcumin: problems and promises.
Mol Pharm 2007; 4(6): 807-18.
[4]
Ohori H,
Yamakoshi H,
Tomizawa M,
Shibuya M,
Kakudo Y,
Takahashi A,
Takahashi S,
Kato S,
Suzuki T,
Ishioka C,
Iwabuchi Y,
Shibata H. Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer.
Mol Cancer Ther 2006; 5(10): 2563-71.
[5] Sadeghizadeh M, Ranjbar B, Damaghi M, Khaki L, Sarbolouki MN, Najafi F, Parsaee S, Ziaee AA, Massumi M, Lubitz W, Kudela P, Paukner S, Karami A. Dendrosomes as novel gene porters-III. J Chem Technol Biot 2008; 83(6): 912-20.
[6] Sarbolouki MN, Sadeghizadeah M, Yaghoobi MM, Karami A, Lohrasbi T. Dendrosomes: a novel family of vehicles for transfection and therapy. J Chem Technol Biotechnol 2000; 75(10): 919-22.
[7]
Babaei E,
Sadeghizadeh M,
Hassan ZM,
Feizi MA,
Najafi F,
Hashemi SM. Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo.
Int Immunopharmacol 2012; 12(1): 226-34.
[8]
Alizadeh AM,
Khaniki M,
Azizian S,
Mohaghgheghi MA,
Sadeghizadeh M,
Najafi F. Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin.
Eur J Pharmacol 2012; 689(1-3): 226-32.
[9]
Jordan CT,
Guzman ML,
Noble M. Cancer stem cells.
N Engl J Med 2006; 355(12): 1253-61.
[10]
He W,
Li K,
Wang F,
Qin YR,
Fan QX. Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis.
World J Gastroenterol 2012; 18(7): 712-9.
[11]
Karoubi G,
Gugger M,
Schmid R,
Dutly A. OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention.
Interact Cardiovasc Thorac Surg 2009; 8(4): 393-7.
[12]
Gazouli M,
Roubelakis MG,
Theodoropoulos GE,
Papailiou J,
Vaiopoulou A,
Pappa KI,
Nikiteas N,
Anagnou NP. OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer.
Mol Carcinog 2012; 51(2): 165-73.
[13]
Leis O,
Eguiara A,
Lopez-Arribillaga E,
Alberdi MJ,
Hernandez-Garcia S,
Elorriaga K,
Pandiella A,
Rezola R,
Martin AG. Sox2 expression in breast tumours and activation in breast cancer stem cells.
Oncogene 2012; 31(11): 1354-65.
[14]
Jung I,
Messing E. Molecular mechanisms and pathways in bladder cancer development and progression.
Cancer Control 2000; 7(4): 325-34.
[15]
Gu J,
Wu X. Genetic susceptibility to bladder cancer risk and outcome.
Per Med 2011; 8(3): 365-374.
[16]
Zhu Z,
Wen J,
Zheng X,
Wang D,
Wang Q,
Fan C. Expression of transcription factor Oct4 in bladder cancer cell line T24 and its effects on the biological characteristics of the cells.
J Huazhong Univ Sci Technolog Med Sci 2009; 29(1): 73-6.
[17]
Xu K,
Zhu Z,
Zeng F. Expression and significance of Oct4 in bladder cancer.
J Huazhong Univ Sci Technolog Med Sci 2007; 27(6): 675-7.
[18]
Schoenhals M,
Kassambara A,
De Vos J,
Hose D,
Moreaux J,
Klein B. Embryonic stem cell markers expression in cancers.
Biochem Biophys Res Commun 2009; 383(2): 157-62.
[19]
Chan KS,
Espinosa I,
Chao M,
Wong D,
Ailles L,
Diehn M,
Gill H,
Presti J Jr,
Chang HY,
van de Rijn M,
Shortliffe L,
Weissman IL. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.
Proc Natl Acad Sci U S A 2009; 106(33): 14016-21.
[20]
Bisht S,
Feldmann G,
Soni S,
Ravi R,
Karikar C,
Maitra A,
Maitra A. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.
J Nanobiotechnology 2007; 5: 3.
[21]
Anand P,
Sundaram C,
Jhurani S,
Kunnumakkara AB,
Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "age-old" solution.
Cancer Lett 2008; 267(1): 133-64.
[22]
Goel A,
Kunnumakkara AB,
Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic.
Biochem Pharmacol 2008; 75(4): 787-809.
[23]
Ravindran J,
Prasad S,
Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?
AAPS J 2009; 11(3): 495-510.
[25] Wang J, Wang Z, Wang H, Zhao J, Zhang Z. Curcumin Induces apoptosis in EJ bladder cancer Cells via Modulating C-Myc and PI3K/Akt Signaling Pathway. World J Onol 2011; 2(3): 113-22.
[26] Tian B, Wang Z, Zhao Y, Wang D, Li Y, Ma L, Li X, Li J, Xiao N, Tian J, Rodriguez R. Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett 2008; 264(2): 299-308.
[27]
Jordan CT. Cancer stem cell biology: from leukemia to solid tumors.
Curr Opin Cell Biol 2004; 16(6): 708-12.
[28]
Ling GQ,
Chen DB,
Wang BQ,
Zhang LS. Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines.
Oncol Lett 2012; 4(6): 1264-8.
[29] Campbell PA, Perez-Iratxeta C, Andrade-Navarro MA, Rudnicki MA. Oct4 targets regulatory nodes to modulate stem cell function. PLoS One 2007; 2(6): e553.
[30] Ruan J, Wei B, Xu Z, Yang S, Zhou Y, Yu M, Liang J, Jin K, Huang X, Lu P, Cheng H. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer. Med Oncol 2013; 30(1): 445.
[31]
Zhao P,
Liu C,
Xu K,
Zheng S,
Li H,
Xu Y,
Xu A,
Li B,
Huang P. [Expression of OCT4 protein in bladder cancer and its clinicopathological implications].
Nan Fang Yi Ke Da Xue Xue Bao 2012; 32(5): 643-6.
[32] Almanaa TN, Geusz ME, Jamasbi RJ. Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines. BMC Complement Altern Med 2012; 12: 195.
[34]
Zhuang W,
Long L,
Zheng B,
Ji W,
Yang N,
Zhang Q,
Liang Z. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci 2012; 103(4): 684-90.
Pathobiology Reserach